Abstract:Deafness, with loss of sensory (hair) cells, results in progressive pathophysiological changes ending in the degeneration of most auditory nerve neurons. It is now possible to consider these events in the broader context of anti-apoptotic survival factors in the peripheral and central nervous system. One consequence of deafferentation of a neuron is the loss of neurotrophins that can lead to a change in oxidative state (formation of free radicals), changes in intracellular Ca(2+), and an up-regulation of apoptotic genes. Interventions that can modify availability of neurotrophins, [Ca(2+)](I), and/or free radical formation or their destructive effects, may preserve the auditory nerve. Some interventions (neurotrophins) may also lead to a regrowth of neurites. Studies in this area are of basic value and also of immediate clinical interest for the application of the cochlear prosthesis to the severe and profoundly deaf, since the benefits of this prosthesis are directly dependent on auditory nerve survival and the proximity of stimulating electrode to neuron. We, and others, have found that auditory nerve degeneration can be prevented by chronic electrical stimulation. We have demonstrated in vivo that this effect can be blocked by tetrodotoxin, thus indicating that propagated action potentials are a necessary condition, and by verapamil (Ca(2+) channel blocker), supporting in vitro studies by others, indicating that L-type Ca(2+) channels are necessary for stimulation-induced rescue of the deafferented auditory nerve. The intensities of electrical stimulation required for rescue are at levels sufficient to express the intermediate-early gene c-fos which can initiate transcription of anti-apoptotic genes and pathways, and up-regulate expression of neurotrophins that may act in an autocrine manner to protect the nerve from death. We, and others, have found that chronic local delivery (osmotic pump and microcannulation of the inner ear fluid spaces) of individual neurotrophins and cocktails of factors can also enhance survival of the deafferented nerve, and some can also initiate a regrowth of degenerated peripheral processes of the nerve into the region of the destroyed sensory epitheliae. Recently, we have shown that this rescue can occur with delayed intervention, after degeneration of some neurons has begun, more closely mimicking the human clinical situation. Finally, we have shown that interventions with antioxidants may also be effective in preventing pathophysiological changes of the auditory nerve following deafness. These studies in the auditory periphery support the 'neurotrophic factor hypothesis' as proposed as a general mechanism underlying neurodegenerative and age-related pathology of the central nervous system. Additional animal studies can yield a rational scientific basis to justify human trials, with a goal to maintain auditory cell survival and initiate and direct fiber growth to the next generation of prosthesis. Intimate contact between electrode and a dense population of auditory neurons should greatly enhance the benefits of these devices for the profoundly deaf.

Atrial Natriuretic Peptide Promotes Neurite Outgrowth and Survival of Cochlear Spiral Ganglion Neurons in vitro Through NPR-A/cGMP/PKG Signaling

Atrial Natriuretic Peptide Improves Neurite Outgrowth from Spiral Ganglion Neurons in Vitro Through a Cgmp-Dependent Manner.

Expression and Localization of Atrial Natriuretic Peptide and Its Receptors in Rat Spiral Ganglion Neurons.

Expression Patterns of Atrial Natriuretic Peptide and Its Receptors Within the Cochlear Spiral Ganglion of the Postnatal Rat

Therapeutic Value of Nerve Growth Factor in Promoting Neural Stem Cell Survival and Differentiation and Protecting Against Neuronal Hearing Loss

Protection and regrowth of the auditory nerve after deafness: neurotrophins, antioxidants and depolarization are effective in vivo

Morphology, Development, and Neurotrophic Regulation of Cochlear Afferent Innervation

Therapeutic Potential of Neurotrophins for Treatment of Hearing Loss.

Expression of Atrial Natriuretic Peptides in Primary Cultured Spiral Ganglion Neurons from Rat Cochlea

A Further Step towards Autologous Auditory Nerve Recovery

Acoustical Stimulus Changes the Expression of Stromal Cell-Derived Factor-1 in the Spiral Ganglion Neurons of the Rat Cochlea

Tissue engineering strategies for spiral ganglion neuron protection and regeneration

Protection of spiral ganglion neurons from degeneration using small-molecule TrkB receptor agonists.

Optogenetically Modified Human Embryonic Stem Cell-Derived Otic Neurons Establish Functional Synaptic Connection with Cochlear Nuclei

Exogenous neuritin restores auditory following cochlear spiral ganglion neuron denervation of gerbils

Ultrasound-Triggered NO Release to Promote Axonal Regeneration for Noise-Induced Hearing Loss Therapy.

Detection of Atrial Natriuretic Peptide and Its Receptor in Marginal Cells and Cochlea Tissues from the Developing Rats

Charge-balanced biphasic electrical stimulation inhibits neurite extension of spiral ganglion neurons.

Neurotrophins, NMDA receptors, and nitric oxide in development and protection of the auditory system

Conditional overexpression of neuritin in supporting cells (SCs) mitigates hair cell (HC) damage and induces HC regeneration in the adult mouse cochlea after drug-induced ototoxicity

Potentiation of Brain-Derived Neurotrophic Factor-Induced Protection of Spiral Ganglion Neurons by C3 Exoenzyme/Rho Inhibitor